BREAKING NEWS: FDA Approves Darolutamide for Metastatic Hormone-Sensitive Prostate Cancer (read more here).
Go here to learn more or to get a mailed copy.
Home » Bio
Specialist, Accounts Payable
Radiation therapy in combination with medicines that..
Robert Den, MD:
Kimmel Cancer Center, Thomas Jefferson University – Philadelphia, PA
Karen Knudsen, PhD, Associate Professor, Departments of Cancer Biology and Urology at the Kimmel Cancer Center, Thomas Jefferson University.
Adam Dicker, MD, PhD, Interim Chair and Professor, Radiation Research and Translational Biology, at the Kimmel Cancer Center, Thomas Jefferson University.
Periprostatic Fat as a Promoter of Prostate..
NorthShore University HealthSystem Research Institute, Illinois
DNA-binding Polyamides as Inhibitors of TMPRSS2-ERG Activity..
Bren Professor of Chemistry
California Institute of Technology
Evaluation of Bindarit, a Novel Inhibitor of..
Professor, Pharmacology & Molecular Sciences
The Johns Hopkins University School of Medicine
Prostate cancer diagnosis and precision medicine treatment..
Jeremy Durack, MD, MS:
Memorial Sloan-Kettering Cancer Center
Howard Scher, MD
Rapid Spectroscopic Assessment of Targeted Prostate Cancer Biopsy Sufficiency at the Point-of-Care
Dr. Dehm completed a BS and PhD..
Scott M. Dehm, PhD:
Masonic Cancer Center, University of Minnesota – Minneapolis, MN
Men with progressive metastatic prostate cancer are..
Justin Drake, PhD:
Rutgers University Cancer Institute of New Jersey
Robert DiPaola, MD
Elucidating Kinase Activation Pathways in Advanced Prostate Cancer
View All Board Members here.
Executive PartnerNonantum Capital Partners
Professor Johann de Bono is Head of..
Institute of Cancer Research
Dr. Angelo De Marzo is a professor..
Johns Hopkins School of Medicine
My mission, “Empowering patients through translational cancer..
Thomas Jefferson University
Dr. Charles G. Drake is a physician-scientist..